These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 10856974)

  • 41. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The pathogenesis and management of disseminated intravascular coagulation.
    Saba HI; Morelli GA
    Clin Adv Hematol Oncol; 2006 Dec; 4(12):919-26. PubMed ID: 17235277
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock.
    Gando S; Otomo Y
    Crit Care; 2015 Feb; 19(1):72. PubMed ID: 25886801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
    Mosad E; Elsayh KI; Eltayeb AA
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current drug treatment strategies for disseminated intravascular coagulation.
    de Jonge E; Levi M; Stoutenbeek CP; van Deventer SJ
    Drugs; 1998 Jun; 55(6):767-77. PubMed ID: 9617592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory role of cytokines in disseminated intravascular coagulation.
    van der Poll T; de Jonge E; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):639-51. PubMed ID: 11740687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New findings on the physiopathology of acute hemolytic transfusion reactions].
    Rakić S
    Med Pregl; 1999; 52(1-2):19-24. PubMed ID: 10352499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protein C inhibitor as an anti-disseminated intravascular coagulation agent--mechanism and modification.
    Fujita M; Izutani W; Takahashi K
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):21-7. PubMed ID: 15320803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PF-04886847 (an inhibitor of plasma kallikrein) attenuates inflammatory mediators and activation of blood coagulation in rat model of lipopolysaccharide (LPS)-induced sepsis.
    Kolte D; Bryant JW; Gibson GW; Wang J; Shariat-Madar Z
    Cardiovasc Hematol Agents Med Chem; 2012 Jun; 10(2):154-66. PubMed ID: 22352684
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
    Maruyama I
    Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Anticoagulant and fibrinolytic systems of the injured vascular endothelial cells].
    Takeya H; Suzuki K
    Rinsho Byori; 1994 Apr; 42(4):333-9. PubMed ID: 8176840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants.
    Taylor FB
    Crit Care Med; 2001 Jul; 29(7 Suppl):S78-89. PubMed ID: 11445739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Protein C and coagulation in sepsis].
    D'Angelo A; Della Valle P; Giudici D; Viganò D'Angelo S
    Minerva Anestesiol; 2004 May; 70(5):339-50. PubMed ID: 15181414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical usefulness of plasma interleukin-6 and interleukin-10 in disseminated intravascular coagulation].
    Seo JW; Kim HK; Lee DS; Cho HI
    Korean J Lab Med; 2007 Apr; 27(2):83-8. PubMed ID: 18094556
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever.
    Elghetany MT; Walker DH
    Am J Clin Pathol; 1999 Aug; 112(2):159-68. PubMed ID: 10439795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced expression of cell-specific surface antigens on endothelial microparticles in sepsis-induced disseminated intravascular coagulation.
    Matsumoto H; Yamakawa K; Ogura H; Koh T; Matsumoto N; Shimazu T
    Shock; 2015 May; 43(5):443-9. PubMed ID: 25608138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of antithrombin on the systemic inflammatory response in disseminated intravascular coagulation.
    Nielsen JD
    Blood Coagul Fibrinolysis; 1998 Nov; 9 Suppl 3():S11-5. PubMed ID: 10102494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia.
    Nguyen TC; Gushiken F; Correa JI; Dong JF; Dasgupta SK; Thiagarajan P; Cruz MA
    Thromb Res; 2015 May; 135(5):1025-30. PubMed ID: 25769494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.